These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33486476)

  • 21. Using the Vitiligo Noticeability Scale in clinical trials: construct validity, interpretability, reliability and acceptability.
    Batchelor JM; Gran S; Leighton P; Howells L; Montgomery AA; Tan W; Ahmed I; Thomas KS
    Br J Dermatol; 2022 Oct; 187(4):548-556. PubMed ID: 35596714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depigmentation patterns of nonsegmental vitiligo: a prospective study of macromorphologic changes in lesions.
    Menchini G; Comacchi C; Cappugi P; Torchia D
    Am J Clin Dermatol; 2013 Feb; 14(1):55-9. PubMed ID: 23329080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into leukotrichia in nonsegmental vitiligo: A cross-sectional study.
    Mogawer RM; Elmasry MF; Mostafa WZ
    Indian J Dermatol Venereol Leprol; 2019; 85(4):374-379. PubMed ID: 30971534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reliability and validity of the Vitiligo Signs of Activity Score (VSAS).
    van Geel N; Passeron T; Wolkerstorfer A; Speeckaert R; Ezzedine K
    Br J Dermatol; 2020 Nov; 183(5):883-890. PubMed ID: 32064583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaire.
    Augustin M; Gajur AI; Reich C; Rustenbach SJ; Schaefer I
    Dermatology; 2008; 217(2):101-6. PubMed ID: 18451647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of the Vitiligo Extent Score for a Target Area (VESTA) to assess the treatment response of a target lesion.
    Bae JM; Oh SH; Kang HY; Ryoo YW; Lan CE; Xiang LH; Kim KH; Suzuki T; Katayama I; Lee SC;
    Pigment Cell Melanoma Res; 2019 Mar; 32(2):315-319. PubMed ID: 30117287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
    Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
    JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of combined excimer laser and platelet-rich plasma for the treatment of nonsegmental vitiligo: A prospective comparative study.
    Khattab FM; Abdelbary E; Fawzi M
    J Cosmet Dermatol; 2020 Apr; 19(4):869-877. PubMed ID: 31541597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Segmental and nonsegmental childhood vitiligo has distinct clinical characteristics: a prospective observational study.
    Mazereeuw-Hautier J; Bezio S; Mahe E; Bodemer C; Eschard C; Viseux V; Labreze C; Plantin P; Barbarot S; Vabres P; Martin L; Paul C; Lacour JP;
    J Am Acad Dermatol; 2010 Jun; 62(6):945-9. PubMed ID: 20466172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meaningful Changes in What Matters to Individuals with Vitiligo: Content Validity and Meaningful Change Thresholds of the Vitiligo Area Scoring Index (VASI).
    Kitchen H; Wyrwich KW; Carmichael C; Deal LS; Lukic T; Al-Zubeidi T; Marshall C; Pegram H; Hamzavi IH; King B
    Dermatol Ther (Heidelb); 2022 Jul; 12(7):1623-1637. PubMed ID: 35773559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
    Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
    Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Psychometric characteristics of questionnaires designed to assess the knowledge, perceptions and practices of health care professionals with regards to alcoholic patients].
    Jaussent S; Labarère J; Boyer JP; François P
    Encephale; 2004; 30(5):437-46. PubMed ID: 15627048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a Disease-Specific Ureteral Calculus Patient Reported Outcome Measurement Instrument.
    Tran MGB; Sut MK; Collie J; Neves JB; Al-Hayek S; Armitage JN; Couturier DL; Wiseman OJ
    J Endourol; 2018 Jun; 32(6):548-558. PubMed ID: 29630385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Qualitative exploration of the renal stone patients' experience and development of the renal stone-specific patient-reported outcome measure.
    Ragab M; Baldin N; Collie J; Tran MGB; Al-Hayek S; S Parsy K; Armitage J; Wiseman O
    BJU Int; 2020 Jan; 125(1):123-132. PubMed ID: 31313440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standardizing serial photography for assessing and monitoring vitiligo: A core set of international recommendations for essential clinical and technical specifications.
    van Geel N; Hamzavi I; Kohli I; Wolkerstorfer A; Lim HW; Bae JM; Lui H; Harris JE; Pandya AG; Thng Tien Guan S; Abdallah M; Esmat S; Seneschal J; Speeckaert R; Grine L; Kang HY; Raboobee N; Xiang LF; Bekkenk M; Picardo M; Taieb A
    J Am Acad Dermatol; 2020 Dec; 83(6):1639-1646. PubMed ID: 31678332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features and treatment outcomes of vitiligo from the patients' perspective: results of a national survey in Germany.
    Radtke MA; Schäfer I; Gajur AI; Augustin M
    Dermatology; 2010; 220(3):194-200. PubMed ID: 20203472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
    J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monochromatic excimer light versus combination of topical steroid with vitamin D3 analogue in the treatment of nonsegmental vitiligo: a randomized blinded comparative study.
    Abdel Latif AA; Ibrahim SM
    Dermatol Ther; 2015; 28(6):383-9. PubMed ID: 26358764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of the body surface area calculation method used in vitiligo extent score vs the hand unit method used in vitiligo area severity index.
    Mogawer RM; Mostafa WZ; Elmasry MF
    J Cosmet Dermatol; 2020 Oct; 19(10):2679-2683. PubMed ID: 32017422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What do Vitiligo Impact Scale-22 scores mean? Studying the clinical interpretation of scores using an anchor-based approach.
    Gupta V; Sreenivas V; Mehta M; Ramam M
    Br J Dermatol; 2019 Mar; 180(3):580-585. PubMed ID: 30085349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.